Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Massimo Colombo

Showing results (251-260 of 372) with videos related to

Pageof 38
Sort By:
Biomed Research International|August 13, 2013
Cirrhosis and rapid virological response to peginterferon plus ribavirin determine treatment outcome in HCV-1 IL28B rs12979860 CC patientsAlessio Aghemo, Elisabetta Degasperi, Maria Grazia Rumi, et al.
Scandinavian Journal of Gastroenterology|April 20, 2012
Transient elastography in patients with celiac disease: a noninvasive method to detect liver involvement associated with celiac diseaseSara Massironi, Roberta Elisa Rossi, Mirella Fraquelli, et al.
Journal of Hepatology|March 19, 2013
Natural killer cell dynamic profile is associated with treatment outcome in patients with chronic HCV infectionBarbara Oliviero, Dalila Mele, Elisabetta Degasperi, et al.
Haematologica|June 30, 2017
Failure of long-term lamivudine prophylaxis in patients with resolved hepatitis B infection undergoing chemotherapy and allogenic hematopoietic stem cell transplantation for hematological malignancies: two case reportsGlenda Grossi, Mauro Viganò, Floriana Facchetti, et al.
Journal of Viral Hepatitis|July 22, 2014
Interferon-ribavirin therapy induces serum antibodies determining 'rods and rings' pattern in hepatitis C patientsCristina Novembrino, Alessio Aghemo, Chiara Ferraris Fusarini, et al.
United European Gastroenterology Journal|February 22, 2019
Imaging of combined hepatocellular-cholangiocarcinoma in cirrhosis and risk of false diagnosis of hepatocellular carcinomaElisabetta Sagrini, Massimo Iavarone, Federico Stefanini, et al.
European Journal of Cancer (Oxford, England : 1990)|July 2, 2013
Regorafenib as second-line therapy for intermediate or advanced hepatocellular carcinoma: multicentre, open-label, phase II safety studyJordi Bruix, Won-Young Tak, Antonio Gasbarrini, et al.
Hepatology (Baltimore, Md.)|January 10, 2013
Cost-effectiveness of sorafenib treatment in field practice for patients with hepatocellular carcinomaCalogero Cammà, Giuseppe Cabibbo, Salvatore Petta, et al.
Nano Letters|November 6, 2014
Etched colloidal LiFePO4 nanoplatelets toward high-rate capable Li-ion battery electrodesAndrea Paolella, Giovanni Bertoni, Sergio Marras, et al.
Hepatology (Baltimore, Md.)|July 2, 2011
Genetic variation in the interleukin-28B gene is not associated with fibrosis progression in patients with chronic hepatitis C and known date of infectionFrancesco Marabita, Alessio Aghemo, Stella De Nicola, et al.
Pageof 38

Showing results (251-260 of 372) with videos related to

Sort By:
Pageof 38
Biomed Research International|August 13, 2013
Cirrhosis and rapid virological response to peginterferon plus ribavirin determine treatment outcome in HCV-1 IL28B rs12979860 CC patientsAlessio Aghemo, Elisabetta Degasperi, Maria Grazia Rumi, et al.
Scandinavian Journal of Gastroenterology|April 20, 2012
Transient elastography in patients with celiac disease: a noninvasive method to detect liver involvement associated with celiac diseaseSara Massironi, Roberta Elisa Rossi, Mirella Fraquelli, et al.
Journal of Hepatology|March 19, 2013
Natural killer cell dynamic profile is associated with treatment outcome in patients with chronic HCV infectionBarbara Oliviero, Dalila Mele, Elisabetta Degasperi, et al.
Haematologica|June 30, 2017
Failure of long-term lamivudine prophylaxis in patients with resolved hepatitis B infection undergoing chemotherapy and allogenic hematopoietic stem cell transplantation for hematological malignancies: two case reportsGlenda Grossi, Mauro Viganò, Floriana Facchetti, et al.
Journal of Viral Hepatitis|July 22, 2014
Interferon-ribavirin therapy induces serum antibodies determining 'rods and rings' pattern in hepatitis C patientsCristina Novembrino, Alessio Aghemo, Chiara Ferraris Fusarini, et al.
United European Gastroenterology Journal|February 22, 2019
Imaging of combined hepatocellular-cholangiocarcinoma in cirrhosis and risk of false diagnosis of hepatocellular carcinomaElisabetta Sagrini, Massimo Iavarone, Federico Stefanini, et al.
European Journal of Cancer (Oxford, England : 1990)|July 2, 2013
Regorafenib as second-line therapy for intermediate or advanced hepatocellular carcinoma: multicentre, open-label, phase II safety studyJordi Bruix, Won-Young Tak, Antonio Gasbarrini, et al.
Hepatology (Baltimore, Md.)|January 10, 2013
Cost-effectiveness of sorafenib treatment in field practice for patients with hepatocellular carcinomaCalogero Cammà, Giuseppe Cabibbo, Salvatore Petta, et al.
Nano Letters|November 6, 2014
Etched colloidal LiFePO4 nanoplatelets toward high-rate capable Li-ion battery electrodesAndrea Paolella, Giovanni Bertoni, Sergio Marras, et al.
Hepatology (Baltimore, Md.)|July 2, 2011
Genetic variation in the interleukin-28B gene is not associated with fibrosis progression in patients with chronic hepatitis C and known date of infectionFrancesco Marabita, Alessio Aghemo, Stella De Nicola, et al.
Pageof 38